Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease
PaperCitations, authors & open-access status
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 72 citations, 2022 year and gold oa status.
72
Citations
2022
Year
gold
OA Status